Lumida
/CTSH
⌘K
Cognizant Technology Solutions Corp

Cognizant Technology Solutions Corp

CTSH
$44.77USD+0.47%+0.21 today

MARKET CAP

21.2B

P/E (TTM)

8.2x

FWD P/E

7.4x

DAY RANGE

$44 – $45

52W RANGE

$37
$87

AI Summary

Stalk
Buy NowMedium

CTSH is in an early, fragile Stage 1 consolidation after a sharp mid-June flush, with the Post-Capitulation pattern confirming selling exhaustion and supply absorption at the lows. Mean Reversion Eligibility at multiyear lows supports a tactical medium-term bullish stance as price tightly tracks and holds above the repaired 9 and 21 EMAs with no visible exhaustion in a neutral OB/OS environment. Short-term timing is favorable due to active Lockout Rally dynamics, allowing for immediate engagement under high forced participation. Long-term downtrend remains intact, anchoring this as a measured counter-trend engagement.

  • Q1 2026 revenue reached $5.4B (+3.9% YoY) with 21% bookings growth.
  • 5,000+ AI engagements and Google Cloud partnership boost enterprise adoption.
  • Negative growth revisions signal decelerating revenue momentum.
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

Cognizant Technology Solutions (NASDAQ: CTSH) is a leading provider of IT services, consulting, and business process solutions. The company operates primarily in the digital transformation space, providing a broad range of services across various sectors such as financial services, healthcare, and technology. Cognizant is positioned to leverage the growing demand for AI-driven transformations, aiming to enhance productivity and operational efficiencies, aiming to secure its place as a pivotal player in the ongoing evolution of enterprise-level technology solutions.

Bull says

  • Q1 2026 revenue reached $5.4B (+3.9% YoY) with 21% bookings growth.
  • 5,000+ AI engagements and Google Cloud partnership boost enterprise adoption.
  • Adjusted operating margin guide raised to 16–16.2% reflects cost discipline.
  • Returned $2B in 2025 ($600M in Q1) via buybacks and dividends.
  • High earnings yield and book-to-price suggest undervaluation; strong balance sheet.
  • Management expects large deal ramps and Estrella acquisition to drive H2 growth.

Bear says

  • Negative growth revisions signal decelerating revenue momentum.
  • Weak profitability factors reflect margin pressure from higher wages.
  • Short interest at 35% indicates bearish market skepticism.
  • Macroeconomic uncertainty may curb discretionary IT spending, especially healthcare.
  • Rising AI competition could compress pricing and erode margins.
  • Execution risk if AI investments fail to meet high client expectations.

Investment themes with CTSH

High Dividend Yield +0.32%

Companies paying above-average dividends

AVGO · JPM · XOM

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 04-30-2026neutral

Transcript signals

Bull points

  • As Ravi noted, our first quarter results demonstrate that our AI builder strategy is resonating in the market.
  • In Q1, we delivered revenue growth in the upper half of our guidance range, 10 basis points of year-over-year adjusted margin expansion, and adjusted diluted EPS growth of 14%.
  • First quarter bookings growth of 21% was one of our strongest in recent history.

Bear points

  • Q1 gross margin decreased by 80 basis points year over year, reflecting impact of our integrated offering strategy and increased compensation cost.
  • Our second quarter guidance includes a more cautious near-term view of discretionary spending based on recent global events and trends.
  • So there is an upfront cost attached to it, but there is downstream savings.
Read full transcript analysis ›